INTRODUCTION {#S1}
============

During the development of the central nervous system (CNS), a huge variety of different cell types has to be generated. For the establishment of functional neural circuits it is a prerequisite that characteristic numbers of each cell type become arranged in a reproducible spatial pattern. This pattern is founded during the formation and specification of neural stem cells. Subsequently, tight temporal control of their proliferation and survival as well as specification, differentiation and survival of their progeny ensures the generation of characteristic cell lineages. *Drosophila melanogaster* is one of the favoured models used to investigate these processes and shares many fundamental mechanisms in CNS development with vertebrate systems (for reviews see [@R26]; [@R104]).

In the embryonic CNS of *Drosophila*, neural stem cells (termed neuroblasts, NBs) can be individually identified by their characteristic time and position of delamination from the neuroectoderm (NE), and the expression of a unique combination of molecular markers ([@R11]; [@R25]; [@R107]). Their specification occurs already in the NE by Cartesian grid-like expression of patterning genes, providing positional information along the anteroposterior (AP) and dorsoventral (DV) axes (for reviews see [@R6]; [@R95]). Hence, each NB generates a unique and almost invariant cell lineage ([@R9]; [@R92]; [@R93]).

Along the AP axis the CNS is composed of segmental units (neuromeres). In the thoracic (T1-T3) and most of the abdominal segments (A1-A8) each hemineuromere originates from a repetitive set of ∼30 NBs ([@R11]; [@R25]). Serially homologous NBs, exposed to similar positional cues, produce similar lineages, although some of these include subsets of cells that specifically differ between segments (reviewed by [@R102]). Neuromeres in the tail region (A9, A10) exhibit a progressively derived character (compared to the assumed developmental ground state in T2; [@R61]). They are formed by only 23 NBs in A9 and by 11 NBs in A10 per hemineuromere, and thus their size is continuously decreased ([@R8]).

Segmental identity and patterning is under the control of the highly conserved Hox genes, each encoding a transcription factor with a DNA-binding homeodomain (e.g. reviewed by [@R68]). During neurogenesis in *Drosophila*, Hox genes have been shown to act in various developmental stages at the level of NE, NBs and their progeny to control cell-fate specification, proliferation and/or apoptosis in a segment-specific manner (for reviews, see [@R85]; [@R87]). Whereas Hox genes clustered in the Antennapedia complex (ANT-C) ([@R54]) control differentiation of the head, gnathal and anterior thoracic segments, those in the Bithorax complex (BX-C) ([@R61]) shape the posterior thoracic and all of the abdominal segments (reviewed by [@R81]). Hox gene expression domains coincide with parasegmental boundaries instead of segmental ones. A parasegment (PS) represents a fundamental genetic unit and consists of the posterior compartment of one segment (expressing the segment polarity gene *engrailed* (*en*) ([@R23]; [@R80]) and the anterior compartment of the next segment (En negative) (reviewed by [@R22]; [@R67]) (e.g. PS14 consists of posterior A8 and anterior A9). The BX-C comprises the genes *Ultrabithorax* (*Ubx*), *abdominal-A* (*abd-A*) and *Abdominal-B* (*Abd-B*) ([@R15]; [@R91]; [@R105]). Arrangement of these genes within the BX-C is collinear with their expression domains along the AP body axis (reviewed by [@R28]; [@R61]) and *Abd-B* is expressed most posteriorly ([@R37]). *Abd-B* contains two distinct genetic elements, which are active in different domains: the morphogenetic (m) subfunction is necessary to generate the morphological diversity of PS10-13, whereas the regulatory (r) element is needed for the identity of PS14-15 ([@R14]).

Here we have investigated the role of the different *Abd-B* isoforms in shaping the most posterior neuromeres of the ventral nerve cord (VNC). We focused on a subset of four NBs and their lineages (NB2-4, NB3-3, NB6-4 and NB7-3) that express the molecular marker Eagle (Eg) ([@R24]; [@R40]). We demonstrate that the r isoform of *Abd-B* (*Abd-B.r*) acts at different levels: It confers abdominal fate to NB6-4 (producing glia exclusively), and it triggers programmed cell death (PCD) of several progeny cells within the NB3-3 lineage. Furthermore, it inhibits the formation of a specific set of NBs. In *Abd-B* null mutants, which show no expression of BX-C genes in PS14-15, NB3-3 and NB6-4 (producing glia plus neurons) in PS14 assume thoracic fate, and in PS15 additional NBs are formed, including NB7-3, which is never generated in PS15 of wild-type embryos. Ectopic expression of the m isoform of *Abd-B* (*Abd-B.m*) leads to a rescue of the *Abd-B* null mutant phenotypes, demonstrating similar potentials of both isoforms. However, *Abd-B.r* requires co-expression of the ParaHox gene *caudal* (*cad*) to repress the formation of NBs in PS15. The combined action of *Abd-B.r* and *cad* is also sufficient to ectopically induce posterior identity in anterior neuromeres. We conclude that *Abd-B* and *cad* are required to inhibit the formation of specific NBs and to modify particular NB lineages, in order to adjust proper size and composition of the terminal neuromeres.

MATERIALS AND METHODS {#S2}
=====================

*Drosophila* strains {#S3}
--------------------

The following fly strains were used: wild type (*Oregon R*); *eg*-Gal4 ([@R45]); *sca*-Gal4 ([@R56]); *elav*-Gal4 ([@R62]); UAS-*cad* ([@R76]) (from Ulrich Schaefer, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany); UAS-*cad* ([@R43]) (from Mi-Ae Yoo); *en*-*lacZ* ([@R36]) (from Alfonso Martinez-Arias, University of Cambridge, UK); *Df*(*3R*)*C4* ([@R51]) (from François Karch); *Df*(*3L*)*H99* ([@R113]), UAS-*P35* ([@R39]), *cad^2^* ([@R64]) and UAS-*nGFP* (all from Bloomington Stock Center); *Abd-B^M1^, Abd-B^M3^, Abd-B^M5^* ([@R91]), *Abd-B^D18^* ([@R41]) and *Abd-B^Uab1^* ([@R51]) (all from Ernesto Sánchez-Herrero); *Ubx^MX12^, abd-A^M1^, Abd-B^M8^* triple mutant ([@R15]), UAS-*Abd-B.r* ([@R86]) and UAS-*Abd-B.m* ([@R16]) (all from James Castelli-Gair Hombría). All experiments were performed at 25°C.

Immunohistochemistry and *in situ* hybridisation {#S4}
------------------------------------------------

Embryos (staging according to [@R13]) were dechorionated, fixed and immunostained following previously published protocols (e.g. [@R79]). The following primary antibodies were used: mouse anti-Abdominal-A (1:200) ([@R55]) (from Ian Duncan); mouse anti-Abdominal-B (1:20) ([@R17]), mouse anti-Invected (1:2) ([@R80]) and mouse anti-Ultrabithorax (1:20) ([@R112]) (all from DSHB); chicken anti-β-Galactosidase (1:1000) (Abcam); guinea pig anti-Caudal (1:400) and guinea pig anti-Runt (1:500) ([@R57]) (from John Reinitz); rabbit anti-Caudal (1:100) ([@R64]) (from Paul Macdonald); rabbit anti-Deadpan (1:100) ([@R7]) (from Harald Vaessin); mouse anti-Eagle (1:100) ([@R50]) (from Chris Doe); rabbit anti-Eagle (1:500) ([@R24]); rabbit anti-Engrailed (1:100) (Santa Cruz Biotechnology); rabbit anti-Eyeless (1:1000) ([@R49]) (from Uwe Walldorf); mouse anti-GFP (1:250) (Roche); rat anti-Gooseberry-proximal (1:2) ([@R116]) (from Robert Holmgren); rabbit anti-Miranda (1:100) ([@R5]) (from Juergen Knoblich); guinea pig anti-Reversed-polarity (1:10,000) ([@R110]).

For *in situ* hybridisation we generated an RNA probe for *Abd-B.m* (616bp) targeting its unique N-terminal protein coding sequence (CDS). The *Abd-B.r* RNA probe (220 bp) is directed against two exons, which are exclusively present in all described r-specific transcripts ([Fig. 3A](#F3){ref-type="fig"}). The probes were obtained by amplification from cDNA pAB713 (*Abd-B.m*) and pAB728 (*Abd-B.r*) ([@R60]) (from Ernesto Sánchez-Herrero) and cloned into pDrive (Qiagen). The following primers were used for amplification: for *Abd-B.m* 5′-CACTGGAGGGAGAAACACTCGC-3′ and 5′-CAACAGCAGCAGCAGCAGCAG-3′; for *Abd-B.r* 5′-CTGTGGGATGGGAACTGACGC-3′ and 5′-GACCAAAAGCACTACCCAAATAACTG-3′.

pDrive was linearised and probes were synthesised by a T7 RNA polymerase using FITC (*Abd-B.m*) or DIG (*Abd-B.r*) RNA labelling Mix (Roche). The hybridisation was carried out as described before ([@R82]; [@R100]) and the probes were diluted 1:5000 (*Abd-B.m*) or 1:1000 (*Abd-B.r*).

As fluorescent secondary antibodies we used the DyLight (Jackson ImmunoResearch) and Alexa (Life Technologies) series. Non-fluorescent secondary antibodies were either biotinylated or alkaline phosphatase-conjugated (Jackson ImmunoResearch). All secondary antibodies were used according to the manufacturer's protocols.

Non-fluorescent stainings were documented on a Zeiss Axioplan microscope; fluorescent confocal images were acquired on a Leica TCS SP2 or SP5 microscope. All images were processed by Adobe Photoshop and Illustrator.

A two-tailed *t*-test was performed for statistical significance (see [Fig. 1K](#F1){ref-type="fig"}, [Fig. 8G](#F8){ref-type="fig"}).

RESULTS {#S5}
=======

*Abd-B* suppresses formation of specific neuroblasts in PS15 {#S6}
------------------------------------------------------------

We previously provided a comprehensive map of NBs generated in the tail region and found NB numbers to be significantly reduced in segments A9 (by 28%) and A10 (by 66%), compared with thoracic and anterior abdominal segments ([@R8]). As Hox gene expression domains coincide with parasegmental instead of segmental boundaries, we calculated NB numbers corresponding to terminal PSs. We used the stem cell marker Deadpan (Dpn) ([@R7]) to label NBs in early stage 12 (St12e) wild-type embryos and found 31.13±0.35 (*n*=8) Dpn-positive cells per side in PS13, 25.88±1.13 (*n*=8) in PS14 and 11.88±0.64 (*n*=8) in PS15 ([Fig. 1A,K](#F1){ref-type="fig"}).

![***Abdominal-B* suppresses the formation of neuroblasts in parasegment 15.** (**A-F**) Flat preparations (maximum projections) of St12e and St13 embryos of the indicated genotype double-stained as illustrated. PSs are depicted on the right and their borders are illustrated by a solid line. (A-C) Dpn serves as a universal NB marker. (D-F) NB2-4 (dorsal location) and NB3-3 clones (ventral location) are En negative and indistinguishable in maximum projections of PS13 (yellow asterisks). The typical medial location of the NB7-3 cluster (En positive) is marked by yellow arrowheads. (D,F) The abdominal NB6-4 clones (consisting of two glia) already downregulated Eg expression. (E) Transformation of abdominal NB6-4 into thoracic fate is indicated by appearance of the neuronal subclone, showing constant Eg expression (white arrows). Ectopic NB7-3 cells in PS15, which are not found in wild type or in *Df*(*3L*)*H99* mutant embryos, are surrounded by broken lines and indicated by white arrowheads. (**G-J**′) The ectopic NB7-3 cells in PS15 of *Abd-B^D18^* mutant embryos were identified by double-staining against Eg (green) and various molecular markers as indicated (red). (**K**) Statistics for the total number of Dpn-positive NBs (per side) of the indicated genotypes in PS13, PS14 and PS15, respectively. ^\*^*P*\<0.05; ^\*\*\*^*P*\<0.001. Error bars represent s.d. ML, midline; WT, wild type.](DEV096099F1){#F1}

As *Abd-B* is expressed most posteriorly of all BX-C Hox genes, we investigated its role in shaping terminal neuromeres. *Abd-B^D18^* is a small deficiency, removing the whole *Abd-B* CDS. In *Abd-B^D18^* mutant embryos, we found the number of Dpn-positive cells in PS15 to be increased (15±0.67, *n*=10), whereas the more anterior PSs show no significant differences compared with wild type ([Fig. 1B,K](#F1){ref-type="fig"}). Thus, normal *Abd-B* expression is required to reduce the number of NBs in PS15. In apoptosis-deficient *Df*(*3L*)*H99* mutant embryos the number of Dpn-positive cells in terminal PSs corresponds to wild type ([Fig. 1C,K](#F1){ref-type="fig"}). This indicates that *Abd-B* does not reduce NB numbers by inducing PCD, but by suppressing the formation of these NBs.

To identify NBs that are affected by this inhibition, we performed antibody stainings against Eg, which in thoracic and anterior abdominal neuromeres of wild-type embryos is expressed in four NBs (NB2-4, NB3-3, NB6-4 and NB7-3) and all of their progeny cells ([@R24]; [@R40]). According to the NB map of the tail region ([@R8]), NB6-4 is formed in PS14 and PS15 (but rapidly downregulates Eg expression). However, NB7-3 and NB3-3 are not formed in PS15, and NB2-4 is not generated in PS14 and PS15 (see also [Fig. 1D](#F1){ref-type="fig"}). Therefore, these NBs are candidate NBs, which could be suppressed by *Abd-B*. In St13 *Abd-B^D18^* mutants ([Fig. 1E](#F1){ref-type="fig"}), as well as in *Df*(*3L*)*H99* mutants ([Fig. 1F](#F1){ref-type="fig"}), we found NB6-4, NB3-3 and NB2-4 to be distributed as in wild type, indicating that *Abd-B* does not affect formation of these NBs. Yet, their lineages displayed some changes: in *Abd-B^D18^* mutants, the NB6-4 lineage in PS14 (100%, *n*=28 hemi-PSs) and occasionally in PS13 (14%, *n*=28) reveals homeotic transformation into thoracic fate, as it consists of neurons in addition to glial cells ([Fig. 1E](#F1){ref-type="fig"}) \[normally only glia in abdominal NB6-4 lineages ([@R93])\]. The NB3-3 lineage in PS14 of St16 *Abd-B^D18^* mutants consists of 12 cells, compared to only six cells in wild type (not shown), corresponding to a transformation into thoracic and anterior abdominal fate ([@R93]). As the size of the NB3-3 lineage is also increased in PS14 of *Df*(*3L*)*H99* mutants (10 cells), *Abd-B* seems to promote PCD in several progeny cells of NB3-3.

Strikingly, in PS15 of *Abd-B^D18^* mutants we found an ectopic Eg-positive cell cluster (on each side; 100%, *n*=28; [Fig. 1E](#F1){ref-type="fig"}), that we never observed in wild type ([Fig. 1D](#F1){ref-type="fig"}) or in *Df*(*3L*)*H99* mutants ([Fig. 1F](#F1){ref-type="fig"}). These cells are negative for Runt (Run) ([Fig. 1G](#F1){ref-type="fig"}), but positive for En ([Fig. 1H](#F1){ref-type="fig"}) and are located within the last En stripe. As they are negative for the glial marker Reversed polarity (Repo) ([Fig. 1I](#F1){ref-type="fig"}), they do not seem to derive from NB6-4. Instead, their Eyeless (Ey) expression unambiguously identifies them as NB7-3 progeny ([Fig. 1J](#F1){ref-type="fig"}). Furthermore, they are located in the same dorsal position as the NB7-3 daughter cells in more anterior neuromeres and their precursor delaminates at St11l-St12e (S5). The cluster consists of up to three cells in St13, five cells in St14, and four cells from St16 on, which is also typical for the NB7-3 cell lineage ([@R9]; [@R50]; [@R78]; [@R92]). We therefore conclude that the ectopic Eg-positive cluster generated in *Abd-B^D18^* mutants corresponds to the NB7-3 lineage. Moreover, its absence in *Df*(*3L*)*H99* mutants indicates that *Abd-B* does not act to induce PCD, but to repress formation of NB7-3 in PS15 of early wild-type embryos (see [Fig. 9A](#F9){ref-type="fig"}). As the phenotype is also found in an *Abd-B^D18^* heterozygous situation, but with lower penetrance (50%) ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S1; [Fig. 9A](#F9){ref-type="fig"}), the effects appear to be dose dependent.

In the following we use NB7-3 as a model to further elucidate the mechanism controlling restriction of NB formation in the tail region.

The neuroblast 7-3 lineage in PS15 of *Abd-B* mutants receives no input from the BX-C {#S7}
-------------------------------------------------------------------------------------

Interactions among Hox genes of the BX-C are characterised by 'posterior prevalence', which means that Hox genes that are active in posterior PSs tend to repress the expression of more anterior Hox genes (for reviews, see [@R27]; [@R75]). Accordingly, in a St14 wild-type embryo the Abd-A protein domain reaches from PS7 to PS13a, whereas in *Abd-B* loss-of-function mutants, Abd-A expression is at least expanded to PS14 ([@R52]; [@R55]; [@R65]). To examine whether the ectopic Eg-positive cells in *Abd-B* mutants arise as a result of expansion of the other genes from the BX-C, we investigated their expression in the VNC. In the loss-of-function allele *Abd-B^M1^*, and in *Df*(*3R*)*C4*, a chromosomal deletion of *Abd-B*, we found the anticipated expansion of Abd-A in the VNC, but we never observed Abd-A expression in the ectopic NB7-3 lineage of PS15, or in the NB3-3 and NB6-4 lineages of PS14 ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S2A,B). However, in *Abd-B^D18^* mutants we found no obvious expansion of the Abd-A domain within the VNC (compare [Fig. 2A,B](#F2){ref-type="fig"}). Recently it has been postulated that *Abd-B* is not necessary for the repression of Abd-A in the VNC, but instead the *iab-8* non-coding RNA ([@R34]), which is also affected in *Abd-B^M1^* and *Df*(*3R*)*C4* but not in *Abd-B^D18^.* Yet, all mutants displayed the same phenotype concerning the Eg pattern ([Fig. 9A](#F9){ref-type="fig"}). *Ubx*, the most anterior gene of the BX-C, is normally expressed from PS5 to PS13 in the VNC ([@R112]). In *Abd-B^D18^* mutants we observed no posterior expansion of Ubx expression ([Fig. 2C](#F2){ref-type="fig"}), which is in agreement with a previous report ([@R97]). In addition, a triple mutant removing the whole BX-C revealed the same Eg pattern in PS14-15 as the *Abd-B* single mutants ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S3A,B; [Fig. 9A](#F9){ref-type="fig"}).

![**Expression of Abdominal-A and Ultrabithorax in the ventral nerve cord of wild type and *Abdominal-B* mutants.** (**A-C**) Flat preparations (maximum projections) of St14 embryos of the indicated genotype double-stained as illustrated. PSs are depicted on the right and their borders are illustrated by a solid line; (A,B) PS6-15 are shown. There is no obvious expansion of Abd-A in *Abd-B^D18^* mutants compared with wild type. (C) Magnification of PS14-15 is shown. (**A′-C**′) Eg expression; (**A′-C**′) Hox gene expression. The wild-type NB7-3 progeny is marked by yellow arrowheads. Ectopic NB7-3 cells are surrounded by broken lines and marked by white arrowheads. Neuronal subclones of thoracic NB6-4 are depicted by yellow arrows; ectopic ones in the abdomen are marked by white arrows. ML, midline; WT, wild type.](DEV096099F2){#F2}

Thus, in *Abd-B* mutant background expression of Abd-A or Ubx is observed neither in the ectopic NB7-3 lineage in PS15, nor in the NB6-4 and NB3-3 clusters in PS14. As a consequence of the missing BX-C input they assume thoracic fate, resembling the ground state (pPS4 + aPS5) ([@R61]).

The r isoform of *Abd-B* is responsible for the inhibition of neuroblast 7-3 formation in PS15 {#S8}
----------------------------------------------------------------------------------------------

The *Abd-B* gene consists of at least four overlapping transcription units ([Fig. 3A](#F3){ref-type="fig"}): Class A \[nomenclature according to Zavortink and Sakonju ([@R114])\] is expressed in PS10-13 and is the only transcript that encodes m function. Class B and C are expressed in PS14-15, γ-transcripts only in PS15, and each of these transcript classes may contribute to r function ([@R10]; [@R21]; [@R60]; [@R90]; [@R114]). To recapitulate the localisation of the genetic elements in the VNC by *in situ* hybridisations, we generated one probe, specific for the A-transcript (*Abd-B.m*) and a second one, directed against all transcripts encoding r function (*Abd-B.r*) ([Fig. 3A](#F3){ref-type="fig"}). The stainings confirmed that in St12e *Abd-B.m* is expressed in PS13 and anterior to it, revealing a sharp posterior border ([Fig. 3B](#F3){ref-type="fig"}), whereas *Abd-B.r* transcripts are exclusively expressed in PS14-15 ([Fig. 3C](#F3){ref-type="fig"}). cDNA sequences revealed the existence of two different protein isoforms: Abd-B.m (encoded by the A-transcript) and Abd-B.r (encoded by the B, C and γ-transcripts). Abd-B.m is larger (55 kDa) and shares a common C-terminus with Abd-B.r, which harbours the homeodomain but has a unique glutamine-rich N-terminus, comprising 223 additional amino acids that are absent in the truncated r protein (30 kDa) ([Fig. 3A](#F3){ref-type="fig"}) ([@R17]; [@R21]; [@R114]). To investigate the wild-type Abd-B protein expression in distinct (Eg-positive) cells of the embryonic VNC, we used an antibody that detects both protein isoforms. As the expression domains of the *Abd-B* transcripts are spatially non-overlapping, it is reasonable to assume that the antibody detects the Abd-B.m or Abd-B.r protein in the respective PSs. Already at St11m, we detected abundant Abd-B.r expression in PS14, including NB3-3, and in PS15a. The expression of Abd-B.m in PS13 appeared rather weak and was restricted to the posterior, dorsolateral part of this PS (see also [@R20]). Neither NB2-4 nor NB3-3 in PS13 revealed expression of Abd-B.m ([Fig. 3D](#F3){ref-type="fig"}). From delamination onwards NB6-4 and NB7-3 of PS14 showed very strong expression of Abd-B.r. However, in PS13 neither NB6-4 nor NB7-3 disclosed any Abd-B.m expression before, or directly after, delamination. The weak Abd-B.m expression in PS13 was still restricted to the posterior, dorsolateral part ([Fig. 3E](#F3){ref-type="fig"}) and did not increase or expand in this PS before St12m (not shown) ([@R20]).

![**Expression of different *Abdominal-B* elements in wild type.** (**A**) The *Abd-B* gene (drawn to scale) according to FlyBase ([@R69]). Lines depict intron sequences; boxes mark exons (black ones show UTRs, coloured ones CDSs). The localisation of the exon probes are illustrated by arrows (solid one=*Abd-B.m* (616 bp); stippled one=*Abd-B.r* (220 bp) spanning over two exons). (**B**,**C**) *In situ* hybridisation of *Abd-B.m* (B) or *Abd-B.r* (C) in a wild-type St12e VNC (flat preparation). PSs are depicted on the right and their borders are illustrated by a solid line. (**B′,C**′) Same stainings in whole mount. (**D**,**E**) Flat preparations (maximum projections) of St11m and St12e *en*-*lacZ* embryos triple-stained against Abd-B (both isoforms), Eg and beta-galactosidase (Beta-Gal). (E) NB7-3 of PS13 and PS14, which underwent their first division, are marked by yellow arrowheads. All other wild-type Eg-positive cells are encircled. Please note the intensive expression of Abd-B.r in the En stripe of PS15, where the formation of NB7-3 is inhibited. (**D′,E**′) Abd-B and Eg staining. (**D′,E**′) Abd-B expression. ML, midline; WT, wild type.](DEV096099F3){#F3}

Next, we analysed *Abd-B* mutants, which specifically disrupt the function of only one isoform. *Abd-B^M3^* and *Abd-B^M5^* both solely disrupt the m function, but possess intact r function (m^-^r^+^) ([@R14]). In both mutants, we found no obvious differences in the Eg pattern ([Fig. 4A](#F4){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S3C; [Fig. 9A](#F9){ref-type="fig"}) compared to wild type ([Fig. 1D](#F1){ref-type="fig"}). This was expected, considering that *Abd-B.m* is not expressed posterior to PS13 and that in *Abd-B* null mutants (m^-^r^-^) the Eg pattern is only affected in PS14 and PS15. Consequently, in *Abd-B^Uab1^*, a mutant specific for the r isoform (m^+^r^-^) ([@R14]), we obtained almost the same phenotype as in the *Abd-B* loss-of-function alleles: significantly enlarged NB3-3 clusters and ectopic NB6-4 neuronal subclones in PS14, as well as ectopic NB7-3 lineages (co-expressing Eg, En and Ey) in PS15 ([Fig. 4B](#F4){ref-type="fig"}, [Fig. 9A](#F9){ref-type="fig"}). Thus, the loss of the *Abd-B.r* isoform is responsible for all described effects. It has been shown before that, in accordance with the 'posterior prevalence' phenomenon, *Abd-B.r* suppresses *Abd-B.m* ([@R14]). Indeed, we observed Abd-B.m expression in PS14 and PS15 of *Abd-B^Uab1^* mutants. However, this expression was visible late (St11m) and dorsolaterally, just like in the unaffected PS13. Neither the neuronal NB6-4 clusters in PS14, nor the ectopic NB7-3 clones in PS15 displayed an early ectopic expression of Abd-B.m ([Fig. 4C](#F4){ref-type="fig"}). A broader expression of Abd-B.m in PS14-15 came up in St12m ([Fig. 4D](#F4){ref-type="fig"}), however, at a lower level compared with Abd-B.r expression in wild type ([Fig. 3E](#F3){ref-type="fig"}) ([@R10]; [@R89]). Thus, Abd-B.m seems to be expressed too late in PS14 and PS15 of *Abd-B^Uab1^* mutants to rescue the phenotype that emerges due to the loss of *Abd-B.r*.

![***Abdominal-B.r*, not *Abdominal-B.m* is responsible for the Eagle pattern phenotype.** (**A-D**) Flat preparations (maximum projections) of St12e, St12m and St13 embryos of the indicated genotype double- or triple-stained as illustrated. PSs are depicted on the right and their borders are illustrated by a solid line. Wild-type NB7-3 cells are in all cases marked by yellow arrowheads. (B-D) Ectopic NB7-3 clones in PS15 are surrounded by broken lines and indicated by white arrowheads. Ectopic NB6-4 neuronal subclones in PS14 are marked by white arrows. (C,D) Gooseberry-proximal (Gsb-p) served as an alternative segmental marker and is expressed anterior to and partially overlapping with En posteriorly ([@R35]). (**C′,D**′) Red channel only. ML, midline.](DEV096099F4){#F4}

Taken together, the isoform *Abd-B.r* is responsible for inhibition of NB7-3 formation in PS15, for specification of abdominal NB6-4 in PS14 and for NB3-3-fate in PS14.

Ectopic *Abd-B.m*, but not *Abd-B.r*, is able to inhibit the formation of neuroblast 7-3 in anterior PSs {#S9}
--------------------------------------------------------------------------------------------------------

As *Abd-B.r* suppresses the formation of NB7-3 in PS15, we tested its ability to inhibit the formation of this NB in anterior PSs, when expressed ectopically. To drive the expression of UAS-*Abd-B.r* we used *scabrous* (*sca*)-Gal4, which from St8 onwards reveals a broad and strong expression in the NE and in the NBs that delaminate from it. Surprisingly, ectopic *Abd-B.r* does not remove NB7-3 (0%, *n*=110 thoracic and abdominal hemi-PSs) ([Fig. 9B](#F9){ref-type="fig"}) or any other Eg-positive cell cluster in more anterior PSs ([Fig. 5A](#F5){ref-type="fig"}). To investigate if the total number of NBs is altered in this situation, we counted Dpn-positive cells in PS4-7. We noticed only a marginal decrease in the number of NBs per hemi-PS (30.67±0.49, *n*=12; [Fig. 5F](#F5){ref-type="fig"}) compared with wild type (31.25±0.46, *n*=8; [Fig. 5E](#F5){ref-type="fig"}, [Fig. 8G](#F8){ref-type="fig"}). In a few cases the ectopic expression of *Abd-B.r* resulted in a homeotic transformation of the thoracic NB6-4 into an abdominal fate, which is accompanied by the loss of its neuronal sublineage (13%, *n*=36 thoracic hemi-PSs). However, the frequency of this homeotic transformation was strongly increased when we ectopically expressed *Abd-B.m* (81%, *n*=48 thoracic hemi-PSs). Furthermore, we observed a reduction in the total number of NBs per hemi-PS (26.65±0.81, *n*=20; [Fig. 5G](#F5){ref-type="fig"}, [Fig. 8G](#F8){ref-type="fig"}), which clearly exceeds the effect of ectopic *Abd-B.r*. This includes efficient removal of thoracic and abdominal NB7-3 cell clusters (50%, *n*=176 thoracic and abdominal hemi-PSs) ([Fig. 5B](#F5){ref-type="fig"}, [Fig. 9B](#F9){ref-type="fig"}). Upon ectopic expression of *Abd-B.m* together with *P35*, a known suppressor of apoptosis, the NB7-3 clusters in anterior PSs could not be rescued (42%; [Fig. 9B](#F9){ref-type="fig"}), which confirms that they do not undergo PCD ([Fig. 5C](#F5){ref-type="fig"}). Additionally, we ectopically expressed *Abd-B.m* by using an *embryonic lethal abnormal vision* (*elav*) driver line, which directs expression in all neuronal tissues from St12l on, but is not expressed in the NE. This late expression of *Abd-B.m* was not able to remove the NB7-3 cells in thorax or abdomen (0%, *n*=152) ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S4; [Fig. 9B](#F9){ref-type="fig"}). These results emphasise that a strong ectopic expression of *Abd-B.m* in the NE (as achieved by the *sca*-Gal4 driver) is required to repress the formation of NB7-3 in more anterior PSs, whereas late expression does not lead to a removal of NB7-3 cells (as in PS13 of wild type).

![**Ectopically expressed *Abdominal-B.m*, but not *Abdominal-B.r* has the potential to suppress the formation of neuroblast 7-3.** (**A-I**) Flat preparations (maximum projections) of St12e, St13 and St14e embryos of the indicated genotypes, double-stained as illustrated. PSs are depicted on the right and their borders are illustrated by a solid line. (A-D) Wild-type NB7-3 cells are marked by yellow arrowheads. Positions where NB7-3 clusters were removed are marked by cyan arrowheads. Neuronal NB6-4 clusters in the thorax are marked by yellow arrows; positions where they are missing are marked by cyan arrows. ML, midline; WT, wild type.](DEV096099F5){#F5}

We also tried to rescue the Eg expression phenotype of *Abd-B^D18^* mutants by applying ectopic *Abd-B.m* in the mutant situation (using *sca*-Gal4). In most cases, we were able to remove the neuronal NB6-4 subclone in PS14 (73%, *n*=11 hemi-PSs) and the ectopic NB7-3 lineage in PS15 (82%, *n*=11 hemi-PSs) ([Fig. 9A](#F9){ref-type="fig"}). The efficiency of this rescue strongly correlated with the disappearance of NB7-3 cell clusters in more anterior PSs ([Fig. 5D](#F5){ref-type="fig"}). This suggests that *Abd-B.m*, if expressed early enough, can completely substitute for *Abd-B.r* function concerning repression of the neuronal NB6-4 sublineage and inhibition of NB formation. In wild type, *Abd-B.m* cannot adopt this function as its expression starts too late.

Why does ectopic *Abd-B.m* possess the potency to suppress formation of specific NBs, whereas ectopic *Abd-B.r* does not? When we compared the ability of the respective constructs to downregulate Ubx expression, we noticed that *Abd-B.m* was very efficient ([Fig. 5I](#F5){ref-type="fig"}) ([@R16]), whereas *Abd-B.r* was not ([Fig. 5H](#F5){ref-type="fig"}). Perhaps ectopic *Abd-B.r* does not mediate a homeotic transformation, because it cannot suppress anterior Hox proteins (see Discussion).

*cad* also suppresses formation of NB7-3 in PS15 {#S10}
------------------------------------------------

It has been claimed that the ParaHox gene *cad* determines the character of the most posterior segment. Although it is not a member of the BX-C, ectopic *cad* expression induces analia development in anterior segments and its loss results in a homeotic transformation into the next anterior segment ([@R76]). *cad* reveals maternal and zygotic expression, sharing a common CDS ([@R73]; [@R72]). In St12m we observed zygotic Cad expression in the NE of PS15 ([@R64]), where it overlaps with the expression domain of Abd-B.r, but it is also expressed posterior to this ([@R90]). Its anterior margin is restricted by the En stripe of PS15, and there is only a minor overlap in the expression of En and Cad ([@R58]) ([Fig. 6A](#F6){ref-type="fig"}). In the VNC we found co-expression of Cad and Abd-B.r in NBs belonging to PS15, although we never observed NBs exclusively displaying Cad expression ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S5A).

![***caudal* mutants exhibit an ectopic neuroblast 7-3 lineage in parasegment 15.** Flat preparations (maximum projections) of St12e, St12m, St13 and St17 embryos of the indicated genotype, double- or triple-stained as illustrated. PSs are depicted on the right and their borders are illustrated by a solid line. (**A**) Domains of Abd-B and Cad expression; (**A**′) Abd-B and En; (**A**′) Cad and En. (**B**) NB pattern in *cad^2^* mutant. (**C**) Regular NB7-3 progeny cells are marked by yellow arrowheads, ectopic ones are marked by white arrowheads and surrounded by broken lines. (**D**) Magnification of a completely differentiated NB7-3 lineage in PS15, forming the NB7-3 typical projections. ML, midline; WT, wild type.](DEV096099F6){#F6}

Considering that Cad is co-expressed with Abd-B.r in NBs of PS15, we wondered whether Cad might also affect NB formation. In zygotic *cad* null mutants, *cad^2^*, we observed a significant increase of NBs in PS15 (14.25±1.26, *n*=4; [Fig. 6B](#F6){ref-type="fig"}) compared with wild type (11.88±0.64, *n*=8; [Fig. 1A,K](#F1){ref-type="fig"}). Similar to *Abd-B^D18^, cad^2^* mutants show an ectopic cluster of cells on each side of PS15, co-expressing Eg and En ([Fig. 6C](#F6){ref-type="fig"}, [Fig. 9A](#F9){ref-type="fig"}). By combining *cad^2^* with *eg*-Gal4, UAS-*nGFP*, we could clearly show that in late stages this cell cluster completely differentiates as a NB7-3 cell lineage, forming its typical contralateral projections ([Fig. 6D](#F6){ref-type="fig"}) ([@R9]; [@R92]). However, different from *Abd-B^D18^*, NBs in PS14 are not affected in *cad^2^* mutants (no ectopic neuronal NB6-4 sublineage or enlarged NB3-3 lineage), as expected from the lack of Cad expression in this PS. The failure to inhibit the formation of NB7-3 in PS15 of *cad^2^* mutants seems to be a recessive effect, as we noticed it only in the homozygous situation, whereas Eg expression in the heterozygotes is indistinguishable from wild type ([Fig. 9A](#F9){ref-type="fig"}). These data show that *cad* is also involved in the suppression of NB formation in PS15.

*cad* and *Abd-B.r* act independently, but need to be co-expressed to efficiently inhibit the formation of NB7-3 {#S11}
----------------------------------------------------------------------------------------------------------------

As both Abd-B and Cad affect NB7-3 formation in PS15, we attempted to clarify their functional relationship.

In *Abd-B^D18^* (and in *Abd-B^Uab1^*) mutants, Cad is still expressed in the ectopically formed NB7-3 in PS15 ([Fig. 7A](#F7){ref-type="fig"}). Conversely, in *cad^2^* mutants we noticed Abd-B expression in cells of the ectopic NB7-3 lineage of PS15 ([Fig. 7B](#F7){ref-type="fig"}), although it seems slightly delayed. Furthermore, neither ectopic *Abd-B.r* nor ectopic *Abd-B.m* was able to activate or repress Cad expression in the VNC, when driven by *sca*-Gal4. Moreover, ectopic *cad* does not change the expression domain and intensity of Abd-B (not shown). These data suggest that Abd-B and Cad do not regulate each other within the VNC, and that they act independently to suppress NB7-3 formation. In *cad^2^*/*Abd-B^D18^* transheterozygotes ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S5B), we observed the same phenotype as in the *Abd-B^D18^* heterozygous situation ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S1; [Fig. 9A](#F9){ref-type="fig"}).

![**Ectopic neuroblast 7-3 cells in parasegment 15 reveal expression of Abdominal-B.r or Caudal.** (**A**,**B**) Flat preparations of St12 and St13 embryos of the indicated genotype double- or triple-stained as illustrated. PSs are depicted on the right and their borders are illustrated by a solid line. Regular NB7-3 cells are marked by yellow arrowheads; ectopic ones are marked by white arrowheads and surrounded by broken lines. (A) Single layer; (B) several layers. (**A′,B**′) Red channel only. ML, midline.](DEV096099F7){#F7}

Although it is not able to reduce the expression of Abd-B, ectopic *cad* strongly downregulates Ubx ([Fig. 8B](#F8){ref-type="fig"}) and Abd-A ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S6A), in this respect fulfilling the 'posterior prevalence' criterion for Hox genes. Ectopic *cad* expression (driven by *sca*-Gal4) was weakly able to inhibit the formation of NB7-3 in anterior PSs (17%, *n*=126 thoracic and abdominal hemi-PSs) ([Fig. 8C](#F8){ref-type="fig"}, [Fig. 9B](#F9){ref-type="fig"}). In agreement with this, the ectopic NB7-3 lineage in PS15 of *Abd-B^D18^* mutants was just missing in one case when we ectopically expressed *cad* (8%, *n*=13 hemi-PSs) ([Fig. 8F](#F8){ref-type="fig"}, [Fig. 9A](#F9){ref-type="fig"}). Additionally, ectopic *cad* was also able to transform thoracic NB6-4 into abdominal identity (50%, *n*=30 thoracic hemi-PSs) ([Fig. 8C](#F8){ref-type="fig"}) and rescued the abdominal NB6-4 fate in PS14 of *Abd-B^D18^* mutants ([Fig. 8F](#F8){ref-type="fig"}). Furthermore, like *Abd-B.m, cad* has the potential to inhibit the formation of further NBs (in addition to NB7-3) in more anterior PSs (27.92±0.64, *n*=13; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S6B; [Fig. 8G](#F8){ref-type="fig"}), although with lower efficiency. However, its ability increases significantly when it is ectopically expressed together with *Abd-B.m* (24.8±0.95, *n*=20; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S6C; [Fig. 8G](#F8){ref-type="fig"}). This is also reflected by repression of NB7-3 in all investigated PSs (100%, *n*=80 abdominal and thoracic hemi-PSs; [Fig. 8D](#F8){ref-type="fig"}, [Fig. 9B](#F9){ref-type="fig"}). Upon ectopic expression of *Abd-B.r* together with *cad*, which reflects their native co-expression in PS15, we observed almost the same efficiency in suppression of NB7-3 (91%, *n*=96 hemi-PSs; [Fig. 8E](#F8){ref-type="fig"}, [Fig. 9B](#F9){ref-type="fig"}) and of other NBs (25.43±1.50, *n*=14; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.096099/-/DC1) Fig. S6D; [Fig. 8G](#F8){ref-type="fig"}), as opposed to the inefficient suppression of NB7-3 upon misexpression of *Abd-B.r* alone.

![***Abdominal-B.r* needs *caudal* to mediate terminal fate.** (**A-F**) Flat preparations (maximum projections) of St13 and St14 embryos of the indicated genotype, stained as illustrated. PSs are depicted on the right and their borders are illustrated by a solid line. (A) In wild type, Ubx is strongly expressed in the VNC and in the periphery. (B) Ectopic *cad* expression leads to an efficient downregulation of Ubx. (B′) shows only blue and red channel. (C-F) Yellow arrowheads mark regular NB7-3 clusters; cyan ones depict positions, where NB7-3 cells disappeared, and white ones (F) highlight ectopic NB7-3 cells in PS15 (additionally surrounded by broken lines). The yellow arrow marks the wild-type neuronal NB6-4 cluster in the thorax (C); cyan arrows point to locations where the neuronal NB6-4 cells disappeared. (**G**) Statistics for the total number of Dpn-positive NBs (per side) of the indicated genotypes in PS4-7. All genotypes were compared to wild type (grey stars) and the ectopic expression of single constructs was compared to corresponding ectopic co-expression (black stars). ^\*^*P*\<0.05; ^\*\*\*^*P*\<0.001; error bars represent s.d. ML, midline; WT, wild type.](DEV096099F8){#F8}

![**Frequencies of neuroblast 7-3 formation.** Diagrams illustrating the relative frequencies of NB7-3 formation in PS15 in different mutant backgrounds (**A**), and the frequencies of NB7-3 suppression in PSs4-14 upon ectopic expression of different constructs (**B**), as indicated. WT, wild type.](DEV096099F9){#F9}

Taken together, although Abd-B and Cad act independently of each other, their combined expression is needed to unfold the full potential concerning inhibition of NB formation.

DISCUSSION {#S12}
==========

A novel role for *Abd-B* and *cad* {#S13}
----------------------------------

During the generation of the *Drosophila* VNC, Hox genes of the BX-C act along the AP axis during different stages of development at the level of NE, NBs and their progeny cells to control segmental patterning (reviewed by [@R87]). In the NE they confer segment-specific intrinsic properties to NBs before their delamination ([@R83]). For example, *abd-A* and *Abd-B* specify NB6-4 to produce the abdominal variant of its lineage (only glial cells) as opposed to its thoracic variant (glia plus neurons), which represents the ground state (no input of homeotic genes) ([@R4]; this study). Accordingly, ectopic expression of *Abd-B.m* leads to transformation of thoracic NB6-4 into abdominal fate (loss of neuronal sublineage). Early function of Hox genes at NE and NB level also includes the determination of segment-specific subpopulations of NBs that persist at the end of embryogenesis to become postembryonic NBs and (after a period of quiescence) resume proliferation in the larva ([@R84]; [@R106]). During later stages Hox genes have been shown to control the specification of particular cell types by segment-specific gene regulation and integration of temporal cues on the level of NBs and their progeny ([@R29]; [@R53]).

A further mechanism by which Hox genes modulate segmental pattern in the CNS is through regulation of PCD. At the level of differentiated progeny cells, segment-specific control of PCD occurs as a late function of Hox genes in the embryonic VNC ([@R71]; [@R88]; [@R99]). At the level of postembryonic NBs, the end of their proliferation is scheduled by Hox genes via PCD during the third instar larval stage ([@R3]). Furthermore, a set of sex-specific NBs in the terminal region of the VNC undergoes PCD during late embryonic/early larval stages only in females ([@R8]). Thus, it appeared likely that PCD also contributes to the reduction of the total number of embryonic NBs in terminal neuromeres (PS14-15) compared with more anterior PSs. Indeed, localised PCD has been shown to occur at segment boundaries in the ectoderm of gnathal and terminal abdominal segments ([@R63]; [@R77]), which is controlled by Hox genes (*Deformed* and *Abd-B*) via activation of pro-apoptotic genes ([@R42]; [@R63]; [@R115]). However, in terminal neuromeres of *Df*(*3L*)*H99* mutant embryos (St12e) we did not observe significant differences in numbers of NBs compared to wild type, indicating that PCD does not account for the diminished number of NBs generated in the tail region. Instead, sizes of metameric units in the blastodermal tail anlagen are significantly reduced, as revealed by fate-mapping data ([@R38]; [@R46]; [@R101]). Specification of these units is under the control of a number of genes, which affect the identity of terminal segments, including *Abd-B, cad, spalt* (*salm* - FlyBase) and *forkhead* ([@R48]; Jürgens and Weigel, 1988; [@R76]; [@R91]). One function of *Abd-B* and probably *cad* involves suppression of ventral structures in terminal segments ([@R58]). If this also affects the NE, the degree of its rudimentation may account for the reduced numbers of NBs that can be formed in these segments.

Our data show that *Abd-B* and *cad* are required in PS15 to suppress the formation of a specific subset of about three to four NBs per side. This could be a consequence of the contribution of these genes to restrict the size of the NE. In this case they would prevent the establishment of only those parts of the NE, which specifically give rise to these NBs. For example, as NB7-3 in more anterior PSs normally derives from the intermediate (along the DV axis) and En-positive NE, one would expect this NE domain to be suppressed by *Abd-B* and *cad* in PS15. Alternatively, this domain may be established, but *Abd-B* and *cad* may suppress the formation of NB7-3 within this region. They could do so by regulating the expression of proneural genes, which define proneural cell clusters in the NE, each singling out an individual NB (reviewed by [@R96]). Indeed, a genetic screen for Hox downstream targets revealed that ectopic expression of *Abd-B* results in a downregulation of *lethal of scute* \[*l*(*1*)*sc*\] ([@R42]), one of the four members of the Achaete-Scute complex ([@R66]). In wild type, L(1)sc is expressed in the proneural cluster that gives rise to NB7-3 and for a short period in the NB itself (S. R. Myneni, G.M.T. and A.R.-O., unpublished results). However, the ectopic co-expression of *cad* and *Abd-B.r* reduces the number of NBs from ∼31 to ∼25 in anterior segments, which is significantly different from the amount observed in wild-type PS15 (∼12). This suggests that additional (so far unidentified) posterior patterning cues are required to suppress the formation of further NBs.

*Abd-B.r* cooperates with *cad* to mediate terminal fate in the VNC {#S14}
-------------------------------------------------------------------

*Abd-B.m* is expressed in PS13 (and anterior to this) and *Abd-B.r* in PS14 and PS15, where it overlaps with the expression of Cad. Our data indicate that *Abd-B.r* is necessary, but not sufficient to mediate terminal fate in the VNC. Upon ectopic expression of *Abd-B.r* we observed no obvious transformation of an anterior PS into posterior fate, regarding total NB number, inhibition of NB7-3 formation or frequent change of NB6-4 identity. In addition, we noticed no detectable changes in Ubx expression in the VNC compared to wild type, although ectopic *Abd-B.r* expression was described to result in a downregulation of *Ubx* transcripts ([@R59]). As shown before, *Abd-B.r* cannot be limited to its regulatory function as a repressor of *Abd-B.m*, as it also possesses a morphogenetic role in activating gene expression ([@R1]; [@R103]). However, a recent publication revealed that ectopic *Abd-B.r* has only a weak morphogenetic capacity in anterior segments, as it very inefficiently downregulates co-factors of anterior Hox genes, competing and antagonising *Abd-B* function ([@R86]). Our data underline these observations and indicate that, in terms of mediating posterior identity in the VNC, *Abd-B.r* requires the co-expression of *cad* to unfold its complete morphogenetic property. This is in line with a previous report, suggesting that both *Abd-B* and *cad* are necessary to repress the formation of ventral structures in terminal PSs ([@R58]). Accordingly, the ectopic expression of *cad* or *Abd-B.r* alone has only minor effects on more anterior PSs ([@R74]; [@R86]; this study). Upon ectopic co-expression in the VNC they seem to contribute complementary functions: *cad* is able to downregulate anterior Hox genes (*Ubx, abd-A*), which may be a prerequisite for *Abd-B.r* to repress NB formation. In contrast, *Abd-B.m* unifies both functions. Why it is equipped with the potency to suppress NB formation, although it does not exhibit this function in its normal expression domain, remains an open question. As the Abd-B.m and the truncated Abd-B.r protein share the same C-terminal region, it may harbour the capability to suppress the formation of NBs, while the N-terminal domain of Abd-B.m may be necessary to downregulate anterior Hox genes. Thus, *cad* might compensate for the missing N-terminal domain of *Abd-B.r*, by downregulating Hox genes. At the protein level, the N-terminal domain of Abd-B.m comprises a huge amount of glutamine runs, known as M or opa repeats ([@R111]). A similar asparagine stretch, which might be functionally equivalent, has been identified in *cad* ([@R73]).

*Drosophila cad* is located on chromosome 2L and belongs to the group of dispersed ParaHox genes, resembling ancient paralogues of the ANT-C and BX-C. *cad* and *Abd-B* might have evolved by duplication from an ancestral ProtoHox gene cluster and therefore reflect evolutionary sisters ([@R12]; reviewed by [@R32]). Accordingly, *cad* shares several features with Hox genes of the BX-C: a Hox typical hexapeptide motif N-terminal to the homeodomain and an intron at the same position as *Abd-B* ([@R33]). As expected for paralogous genes, we observed overlapping domains of Cad and Abd-B.r in the VNC. Ectopic *cad* expression efficiently downregulates Ubx- and Abd-A expression. However, in contrast to previous observations in genital discs ([@R76]), we found no evidence for a downregulation of Abd-B in the VNC, which would be an exception from the 'posterior prevalence' rule.

There exist three *cad* homologues in mammals: *Cdx1, Cdx2* and *Cdx4* ([@R30]). In mouse (*Mus musculus*) they are expressed collinearly and overlap in the caudal embryonic neural tube ([@R2]; [@R31]; [@R70]). Mutations result in anterior homeotic transformations and reveal functional redundancy in the control of posterior identity ([@R19]; [@R18]; [@R98]; [@R108]; [@R109]), suggesting a conserved function between *Mus musculus* and *Drosophila*.
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